Follow-up time points | |||||
---|---|---|---|---|---|
Outcome measure | Description of prognostic variable | Prognostic variable | 2 weeks | 3 months | 12 months |
Diff. of. adj. R2 | Diff. of. adj. R2 | Diff. of. adj. R2 | |||
Pain intensity (Numeric Rating Scale, 0–10) | LCA-derived subgroupings | Single-stage subgroups | 0.041** | 0.013* | 0.033** |
Two-stage subgroups | 0.039** | 0.015* | 0.021* | ||
Existing subgrouping tools | STarT Back Tool | 0.023** | 0.004 | 0.008* | |
Quebec Task Force classification | 0.007 | 0.012* | 0.005 | ||
Baseline characteristics | Baseline back pain intensity (0–10 Numeric Rating Scale) | 0.024** | 0.002* | −0.003* | |
Baseline leg pain intensity (0–10 Numeric Rating Scale) | 0.049** | 0.004* | 0.027** | ||
Baseline disability (RMDQ-23) (0–100 = highest disability) | 0.026** | 0.001 | 0.007* | ||
Results of first stage of two-stage LCA | All domain-specific patient categorisations | 0.052** | 0.047** | 0.074** | |
Disability (23-item Roland Morris Disability Questionnaire, proportional score) | LCA-derived subgroupings | Single-stage subgroups | 0.183** | 0.084** | 0.051** |
Two-stage subgroups | 0.174** | 0.084** | 0.044** | ||
Existing subgrouping tools | STarT Back Tool | 0.105** | 0.059** | 0.023** | |
Quebec Task Force classification | 0.033** | 0.037** | 0.029* | ||
Baseline characteristics | Baseline back pain intensity (0–10 Numeric Rating Scale) | 0.057** | 0.013* | 0.009* | |
Baseline leg pain intensity (0–10 Numeric Rating Scale) | 0.052** | 0.036** | 0.048** | ||
Baseline disability (RMDQ-23) (0–100 = highest disability) | 0.199** | 0.069** | 0.049** | ||
Results of first stage of two-stage LCA | All domain-specific patient categorisations | 0.232** | 0.123** | 0.101** |